Genus-optimized strategy for the identification of chlamydial type III secretion substrates

被引:20
|
作者
Hovis, Kelley M. [1 ]
Mojica, Sergio [1 ]
McDermott, Jason E. [2 ]
Pedersen, Laura [1 ]
Simhi, Chana [1 ]
Rank, Roger G. [3 ]
Myers, Garry S. A. [4 ]
Ravel, Jacques [4 ]
Hsia, Ru-ching [5 ]
Bavoil, Patrik M. [1 ]
机构
[1] Univ Maryland, Sch Dent, Dept Microbial Pathogenesis, Baltimore, MD 21201 USA
[2] Pacific NW Natl Lab, Richland, WA 99352 USA
[3] Arkansas Childrens Hosp, Res Inst, Little Rock, AR 72202 USA
[4] Univ Maryland, Sch Med, Inst Genome Sci, Baltimore, MD 21201 USA
[5] Univ Maryland, Sch Dent, Core Imaging Facil, Baltimore, MD 21201 USA
来源
PATHOGENS AND DISEASE | 2013年 / 69卷 / 03期
基金
美国国家卫生研究院;
关键词
Chlamydia; type III secretion; effector; YERSINIA-PSEUDOTUBERCULOSIS; TRANSLOCATED PROTEIN; PNEUMONIAE; INFECTION; CYCLE; LOCALIZATION; CHAPERONES; EXPRESSION; PREDICTION; DEATH;
D O I
10.1111/2049-632X.12070
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Among chlamydial virulence factors are the type III secretion (T3S) system and its effectors. T3S effectors target host proteins to benefit the infecting chlamydiae. The assortment of effectors, each with a unique function, varies between species. This variation likely contributes to differences in host specificity and disease severity. A dozen effectors of Chlamydia trachomatis have been identified; however, estimates suggest that more exist. A T3S prediction algorithm, SVM-based Identification and Evaluation of Virulence Effectors (SIEVE), along with a Yersinia surrogate secretion system helped to identify a new T3S substrate, CT082, which rather than functioning as an effector associates with the chlamydial envelope after secretion. SIEVE was modified to improve/expand effector predictions to include all sequenced genomes. Additional adjustments were made to the existing surrogate system whereby the N terminus of putative effectors was fused to a known effector lacking its own N terminus and was tested for secretion. Expansion of effector predictions by cSIEVE and modification of the surrogate system have also assisted in identifying a new T3S substrate from C.psittaci. The expanded predictions along with modifications to improve the surrogate secretion system have enhanced our ability to identify novel species-specific effectors, which upon characterization should provide insight into the unique pathogenic properties of each species. The manuscript describes the application of new algorithms for computational discovery of type III secretion substrates in Chlamydiae, a group of pathogenic bacteria with limited experimental tools available for virulence gene discovery.
引用
收藏
页码:213 / 222
页数:10
相关论文
共 50 条
  • [41] A tandem affinity purification strategy to isolate proteins interacting with type III secretion chaperones
    Tsai, T.
    Van Dijk, K.
    PHYTOPATHOLOGY, 2009, 99 (06) : S130 - S130
  • [42] A novel strategy to control Pseudomonas syringae through inhibition of type III secretion system
    He, Lu-Lu
    Wang, Xin
    Rothenberg, Dylan O'Neill
    Xu, Xiaoli
    Wang, Hai-Hong
    Deng, Xin
    Cui, Zi-Ning
    PESTICIDE BIOCHEMISTRY AND PHYSIOLOGY, 2023, 194
  • [43] Treatment of Chlamydia trachomatis with a small molecule inhibitor of the Yersinia type III secretion system disrupts progression of the chlamydial developmental cycle
    Wolf, K.
    Betts, H. J.
    Chellas-Gery, B.
    Hower, S.
    Linton, C. N.
    Fields, K. A.
    MOLECULAR MICROBIOLOGY, 2006, 61 (06) : 1543 - 1555
  • [44] Anti-Idiotypic Nanobodies Mimicking an Epitope of the Needle Protein of the Chlamydial Type III Secretion System for Targeted Immune Stimulation
    Koroleva, Ekaterina A.
    Goryainova, Oksana S.
    Ivanova, Tatiana I.
    Rutovskaya, Marina V.
    Zigangirova, Naylia A.
    Tillib, Sergei V.
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (04)
  • [45] Identification of a novel prophage regulator in Escherichia coli controlling the expression of type III secretion
    Flockhart, Allen F.
    Tree, Jai J.
    Xu, Xuefang
    Karpiyevich, Maryia
    McAteer, Sean P.
    Rosenblum, Ronen
    Shaw, Darren J.
    Low, Christopher J.
    Best, Angus
    Gannon, Victor
    Laing, Chad
    Murphy, Kenan C.
    Leong, John M.
    Schneiders, Thamarai
    La Ragione, Roberto
    Gally, David L.
    MOLECULAR MICROBIOLOGY, 2012, 83 (01) : 208 - 223
  • [46] Identification of proteins secreted via Vibrio parahaemolyticus type III secretion system 1
    Ono, T
    Park, KS
    Ueta, M
    Iida, T
    Honda, T
    INFECTION AND IMMUNITY, 2006, 74 (02) : 1032 - 1042
  • [47] Identification of Translocation Inhibitors Targeting the Type III Secretion System of Enteropathogenic Escherichia coli
    Muehlen, Sabrina
    Zapol'skii, Viktor A.
    Bilitewski, Ursula
    Dersch, Petra
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2021, 65 (12)
  • [48] Identification of Novel Type III Secretion Chaperone-Substrate Complexes of Chlamydia trachomatis
    Pais, Sara V.
    Milho, Catarina
    Almeida, Filipe
    Mota, Luis Jaime
    PLOS ONE, 2013, 8 (02):
  • [49] Effective Identification of Bacterial Type III Secretion Signals Using Joint Element Features
    Wang, Yejun
    Sun, Ming'an
    Bao, Hongxia
    Zhang, Qing
    Guo, Dianjing
    PLOS ONE, 2013, 8 (04):
  • [50] Identification of a virulence locus encoding a second type III secretion system in Salmonella typhimurium
    Shea, JE
    Hensel, M
    Gleeson, C
    Holden, DW
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (06) : 2593 - 2597